Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
CHINOOK THERAPEUTICS, INC. (KDNY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/05/2020 |
8-K/A
| Financial Statements and Exhibits Interactive Data |
| 03/29/2019 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/13/2016 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of Deloitte & Touche LLP relating to the financial statements of Aduro Biotech Holdings, Europe B.V. (formerly known as BioNovion Holding B.V.) (“BioNovion”)",
"Audited consolidated financial statements of BioNovion as of and for the year ended December 31, 2014 and the notes related thereto",
"Unaudited condensed consolidated financial statements of BioNovion as of and for the nine months ended September 30, 2015 and September 30, 2014 and the notes related thereto",
"Unaudited pro forma condensed combined financial information of Aduro Biotech, Inc. and BioNovion as of and for the nine months ended September 30, 2015 and the year ended December 31, 2014 and the notes related thereto" |
|
| 11/04/2015 |
8-K/A
| Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
|
|